(searched for: doi:10.17352/2455-5495.000036)
Published: 28 September 2021
Archives of Renal Diseases and Management pp 003-009; https://doi.org/10.17352/2455-5495.000036
From the establishment of nearly universal health coverage for end stage renal disease in 1972 to 2021, the primary treatment modality has been in-center hemodialysis despite significant advances in home therapies such as peritoneal dialysis and home hemodialysis. There are many theories as to why peritoneal and home hemodialysis lack so far behind in prescriptions with profitability and or a patient’s compliance or support leading the logical explanations. But 2020 was a different year with the surge in COVID-19 cases.